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According to the International System for Human Cytogenetic Nomenclature (ISCN) human 
chromosomes (2n=46) are divided into two groups (Shaffer et al., 2009). These are the two 
sex chromosomes or gonosomes (X,Y) and the 44 non-sex chromosomes or autosomes, 
respectively. Chromosomes of the latter group are numbered as 1 to 22, according to their 
decreasing size. Autosomes in somatic cells are comprised of two homologous, genetically 
identical chromosomes. 
The time of the first conference for nomenclature in 1959 is called the pre-banding area. 
Individual chromosomes could not yet be ascertained beyond reasonable doubt. Thus it 
happened that the second smallest chromosome, chromosome 21, which had been analysed 
three times in the patient’s karyotype, was believed to cause Down Syndrome (DS). Later 
studies showed that DS is trisomic in the smallest chromosome. To avoid conflict between 
previous and subsequent publications, the position of the two smallest chromosomes (21 
and 22) was switched, resulting in the definition of DS as trisomy 21. 
The relative length of chromosome 21 is 1.9 ± 0.17 % of the total length of the human 
genome, and its size is approximately 60 Mb. Chromosome 21 belongs to the acrocentric 
chromosomes, i.e. the centromere is localised closer to the end of the short arm (p). The short 
arm 21p is heterochromatic but consists of different types of repetitive DNA (Figure 
1)(Wyandt and Tonk, 2004). 
The relative length of the short arm of chromosome 21 comprises 30 % of its total length 
(Figure 1). Variants in brilliant fluorescence after QFQ-staining are diagnosed in 2.0 % of band 
p11.2 and 10.0 % of band p13. Duplications in p12 show a frequency of 0.7-1.3 % and 0.1 % in 
the satellites of p13. Deletions in all three regions (p11.2, p12, p13) are rare (Kalz et al., 2004). 
These frequencies are derived from population studies based on Europeans. Significant 
differences in comparison to other ethnic groups have been observed (Kalz et al., 2005). The 
polymorphic regions in the short arm of chromosome 21 allowed the first studies on the 
parental origin of trisomy 21 (Mikkelsen et al., 1980).  
The long arm (q) of chromosome 21 is euchromatic, with the exception of the peri-
centromeric region q11.1 and the distal telomere.  
Chromosomes are usually presented and analysed in the metaphase of mitosis after in vitro 
cultivation, which is not identical to their appearance in vivo. Among the differentiated cells,   
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Fig. 1. Structure and morphology of chromosome 21. Ideogram according to the ISCN 
(Shaffer et al., 2009). 
only some (i.e. T-lymphocytes in a blood sample) can be stimulated in vitro to enter the cell 
cycle again and thus represent a selected cell population. In addition, cells are treated with 
colcemid. This substance arrests the chromosomes in the c-metaphase of mitosis and, at the 
same time, increases the contraction of chromosomes, rendering the centromeres and the 
fissure between the two chromatids visible (Figure 2a).  
1.2 Structure 
The central part of the centromere of chromosome 21 consists of ┙-satellite DNA that is 
almost identical to the centromere of chromosome 13 (homology 99.7%)(Figure 1). On both 
sides ┙-satellite DNA is flanked by ┚-satellite DNA. These two non-coding regions can vary 
significantly in size through duplication or deletion. They are irrelevant for the carrier, 
unless their length is less than 20 % of the average length of the region and thus prevents the 
normal development of the kinetochores. This would result in the failure of exact separation 
of the chromatids in the anaphase of mitosis (Waye et al., 1989; Mitchell et al., 1992).  
Distal of the ┚-satellite DNA, satellite DNA class III is situated on the short arm (p11.2). 
Significantly varying in size, this band shows a specific absorption of DNA-dyes. Therefore, 
it is defined as a polymorphic region.  It is followed in the short arm by the band p12, which 
is also named the nucleolus organising region (NOR) and contains the ribosomal RNA-
genes. It is characterised by its slightly lateral expansion (satellite stalks). It is polymorphic 
and can be deleted or amplified (Tagarro et al., 1994a). The most distal regions of the short 
arms are the satellites (p13 or s), consisting of Sat I DNA with the telomeres at the ends 
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(Tagarro et al., 1994b). Satellites are also polymorphic varying in size and staining 
characteristics. They also have the ability to duplicate. 
In describing the structure of the short arm of chromosome 21, only the main components of 
the different bands are mentioned. Especially p11.1, p11.2, and p13 contain further 
subgroups of repetitive DNA. 
 
 
a)      b) 
Fig. 2. Routine diagnostic workup for identification of trisomy 21. a) Standard karyotype 
(47,XY,+21) by GTG banding (by kind courtesy of U. Mau-Holzmann, Tübingen). b) 
Interphase FISH showing three signals of chromosome 21 and two of chromosome 13 
(LSI21:21q22.13q22.2; AneuVysion multicolor DNA probe Kit, Vysis). 
According to the literature, the proximal heterochromatic region of the long arm (q11.1) of 
chromosome 21 consists of ┚-satellite DNA boarding the central ┙-satellite DNA and 
followed distal by Sat I DNA (Waye et al., 1989; Mitchell et al., 1992; Tagarro et al., 1994a, 
1994b). The main part of the long arm is euchromatic. AT- and GC-rich bands have 
characteristic sequences and can be differentiated by their typical staining features (figure 
1). These bands of single copy DNA are interspersed by non-coding repetitive DNA (SINEs 
and LINEs).  
1.3 Aneuploidy and gene content 
A complete or partially aneuploid chromosome is associated with a pathologic phenotype in 
the carrier, the expression of which depends on the type and amount of the aberrant genetic 
material. 
In contrast to chromosome 22, chromosome 21 consists of a high number of AT sequences 
which contain a smaller amount of vitality-determining genes than the GC-rich ones. 
GC-rich or housekeeping genes are expressed in most cell types. They lead to proteins that 
carry out various metabolic and structural functions. In contrast, the AT-rich genes are 
tissue-specific and are only active in certain cell types while being inactivated in others by 
methylation. This gene inactivation is accompanied by a more condensed structure of the 
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chromatin and, consequently, the DNA of these genes is not accessible to the transcription 
factors. These AT-rich DNA regions show a higher staining intensity and can thus be 
localised by chromosome analysis.  
Because of its high content of AT-rich regions, trisomy 21 is compatible with life, and in the 
majority of cases, leads only to retardation in the development of the carrier and not, as in 
trisomy 22, to lethality.  
The gene map of chromosome 21 was initially constructed by combining the analyses of 
small structural aberrations with the results of different gene product analyses (dosage 
effect). Chromosome 21 was sequenced in 2000 (Hattori et al., 2000), and 225 loci (genes) 
were identified, which was less than expected. This might explain the relatively mild 
phenotype of the carriers.  
In the following years, a high number of small regions in 21q has been analysed in order to 
localise the DS critical region (Figure 3)(Wong, 2011), but recent investigations revealed in 
contrast to the first assumptions that a direct genotype-phenotype correlation does not exist, 
since a large number of gene products from chromosome 21 also influences gene products 
and their function on heterologous chromosomes (Gardner and Sutherland, 2004; 
Weinhaeusel et al., 2011). 
 
 
(AMKL acute megakaryocytic leukemia; TMD transient myeloproliferative disorder; DST duodenal 
stenosis; IA inperforate anus; HSCR Hirschsprung disease) 
Fig. 3. Genotype-phenotype correlation in trisomy 21 based on partial trisomy 21 cases (from 
Korbel et al., 2009). (with kind permission of J.R. Korenberg) 
2. Historic development of the cytogenetics of DS 
DS was the first malformation complex that could be delineated as a chromosome 
abnormality in 1959. This was enabled by the new technology to prepare chromosomes in 
Bayesian Probabilities for Gene Contribution in a set of Segmental Trisomies 
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the metaphase of mitosis. In the early years, mitoses were analysed after direct preparations 
of bone marrow cells and long term cell cultures of tissue biopsies. Starting in 1960, the 
lymphocyte culture of peripheral blood was established. Thereby screening of handicapped 
persons on a large scale became possible. At the beginning of the 1980s, prenatal diagnoses 
were started for high-risk groups. 
Any extension of the spectrum of investigations, any more precise definition of the 
localisation of the aberration and characterisation of the patients´ symptoms were combined 
with an improvement of the investigation methods. 
The direct preparation of meristematic somatic cells was followed by long-term and short-
term cell cultures of differentiated somatic cells removed postpartum, by the culture of 
amniotic fluid specimen and biopsy of chorionic villi, as well as the analysis of germ cells 
and their precursor stages in certain special cases, of polar bodies and early postzygotic 
stages like morula and gastrula in preimplantation diagnostics.  
Initially, the presentation of chromosomes was only possible through homogeneous 
staining, which was succeeded by application of radioactive markers and subsequently of 
the differentiated characterisation of the chromosomal banding patterns (GTG, GAG, QFQ, 
RBG, RBA, CBG, and others). 
Today, a necessary requirement in diagnostic investigations is a high differentiation of the 
euchromatin (usually 550 bands per genome). By that way, structural aberrations of 
chromosome 21 can be safely detected microscopically, starting with a minimal length of 5 
Mb. In the 1980s, fluorescence-in-situ hybridisation (FISH) as a new technique was 
introduced (Figure 2b). By FISH the characterisation of either the entire euchromatin or the 
centromeric areas or selected euchromatic bands with specific DNA-probes became possible. 
Simultaneously, this allowed the analysis of cells in interphase and the rapid investigation 
of larger amounts of cells without cell culture. This so-called rapid aneuploidy testing is 
especially important for prenatal diagnostics. 
Further improvement of the investigation spectrum provided the development of the 
comparative genomic hybridisation (CGH) with the advancement to the microarray, which 
has been depicting an improvement and specification of diagnostics on the molecular-
genetic level through development of specific tiling arrays. 
The newest development is next-generation sequencing. This method is still known to be in 
trial tests, and its establishment in diagnostics is to be expected. 
The various methods of investigation are often combined to improve diagnostics. 
3. Types and frequencies of chromosome 21 aberrations 
In addition to the predominance of standard trisomy 21 as the cause of DS, further types of 
aberrations exist. They differ in relation to the type of abnormality, and they lead to 
different prognoses as to the chances of development of the carrier and recurrence risks for 
the relatives of a carrier. 
Therefore, the indication for a chromosome analysis is always given in the presence of the 
distinct phenotype of DS. 
3.1 Standard trisomy 21 
In this type of aberration, the carrier has 47 chromosomes, including three chromosomes 21. 
It accounts for nearly 90% of DS cases. Standard trisomy 21 typically occurs sporadically, 
therefore the recurrence risk is low.  
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The majority of free trisomy 21 cases (85-90%) originates from errors in maternal meiosis. In 
particular, maternal meiosis I is the most frequently affected stage of nondisjunction (>75%), 
whereas maternal meiosis II errors account for >20%. In 5% of free trisomy 21, paternal 
meiotic errors can be observed, here meiosis II nondisjunction is more frequent than meiosis 
I errors. In addition, postzygotic mitotic errors have also been reported (5%). The 
predominant influence of disturbed maternal meiosis is reflected by the decreased number 
of of chiasmata in meiosis I increasing with maternal age. Indeed, the reason for this 
association is unknown, however numerous hypotheses have been proposed (for review: 
Hultén et al., 2010). 
3.2 Robertsonian translocations 
Trisomy 21 due to an unbalanced translocation of chromosome 21 with a hetero- or 
homologous acrocentric, satellite-bearing chromosome (13, 14, 15, 21, 22) is called a 
Robertsonian translocation. However, the frequency of translocation partners varies and is a 
result of homologies in the heterochromatin of the short arm, thus leading to failures in the 
pairing of meisosis I. The resulting fusion products can be monocentric or dicentric with an 
inactive centromere.  
In monocentric translocation chromosomes, the centromere can derive from each of the two 
partners or can be a hybrid structure originating from both of them. 
Robertsonian translocations involve about 5% of the cases of trisomy 21. Approximately 75% 
are formed de-novo in the carrier , and 25% are familial ( for review: Gardner and Sutherland, 
2004). Among these, translocation 21/21 is an unusual rearrangement, but in the majority of 
cases, it is not a fusion of homologous but the formation of an isochromosome. 
In general rule, carriers of the balanced Robertsonian translocation display only 45 
chromosomes, the unbalanced ones show 46, as in the majority of carriers, and two short-
arm regions are lost. The loss of two NOR-regions does not lead to clinical symptoms in the 
carriers of balanced translocations.  
Among the different heterologous translocations of the acrocentric chromosomes with 
chromosome 21, the combination with chromosome 14 (rob(14q21q)) is the most frequent 
one with about 60%. This is followed by the translocation rob(21q21q) or by the formation of 
isochromosome i(21q21q), respectively, in 35% of the cases. The other translocations are rare 
and do not exceed 5%. (for review: Gardner and Sutherland, 2004) 
Current studies of meiosis are leading to new insights on frequency of formation and 
postzygotic selection of Robertsonian translocations in familial cases. These studies are largely 
based on analyses of translocation rob(14q21q) as the most common subgroup. According to 
these, women with a balanced translocation have an aberrant karyotype in about 20 % of their 
polar bodies as well as in the oocytes and men in 10-15% of their sperms. These frequencies 
decrease postzygotically in the course of the development of the embryo, therefore the risk of a 
child with heterologous translocation trisomy 21 amounts to only 8% if the mother is the 
carrier and to 4 % with the father (for review: Gardner and Sutherland, 2004). 
It is noticeable that in families with translocations, children with a normal phenotype carry a 
balanced translocation more often than the normal karyotype if the origin is maternal 
(60:40), while the ratio is equal with paternal origin (50:50).  
3.3 Reciprocal translocations 
Reciprocal translocations are caused by the exchange of euchromatic regions of chromosome 
21 with the euchromatin of different autosomes or gonosomes. In addition to trisomic 
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regions in various length and location of chromosome 21, unbalanced forms at the same 
time show partial monosomy for the exchanged regions of the second translocation 
chromosome. As a result, the phenotype in the carriers of unbalanced translocations is not 
consistent. 
Caused by the rare occurrence of these translocations, there are no reliable data for their 
incidence, a frequency of less than 1:1000 standard trisomies can be assumed. According to 
the literature, the most common partners for a reciprocal translocation seem to be the 
chromosomes 18 and 22 (Schinzel, 2001). 
3.4 Duplications 
This type of aberration is always formed de-novo in carriers with a noticeable pathologic 
phenotype. If the duplicated segment is only of small size or originated from a 
postzygotic mosaic, the impairment of the carrier may be mild, and he might have an 
almost unrestricted life opening the possibility of inheriting the duplication to his 
offsprings.  
A duplication in the cells of the carrier can be caused by an unequal pairing of homologous 
chromosomes in the pachytene of meiosis I and an aberrant crossing-over as the 
consequence. 
A paracentric inversion in the long arm of a parental chromosome 21 may present an 
increased risk for the formation of a duplication. According to published cases, the size of 
the duplicated region can vary significantly, and so far, no preferential sites for the exchange 
have been documented. With the few existing case reports, no data concerning the 
frequency of duplications can be given. 
3.5 Submicroscopic aberrations 
Investigations with FISH probes and applications of molecular-genetic methods for small 
euchromatic regions enabled the detection of structural aberrations in chromosome 21 in a 
size of less than 5 Mb.  The amount of disorders that can be attributed to small duplications 
and deletions of chromosome 21 therefore has risen significantly within the last years. The 
phenotype of the carriers is predominantly not characteristic for the DS. 
3.6 Gene mutations 
Meanwhile, extensive genotype-phenotype correlations on the basis of structural aberrations 
of chromosome 21 have been reported, which help to narrow down the DS critical regions 
(Figures 3, 4)(for review: Korbel et al., 2009). A small number of genes has been proposed to 
cause the specific DS features, and among them are: DSCR1, DYRK1A or APP (for further 
details see other chapters of this book). 
3.7 Mosaicism 
The frequency of trisomy 21 mosaics after chromosomal analysis is about 3-5 %. This 
number is most likely too small since tissue-specific mosaics cannot always be detected. 
Mosaics always originate from mitotic aberrations during the early postzygotic 
development of the conceptus. Their formation may be caused by an aberrant zygote 
loosing one of the three chromosomes 21 of a standard trisomy in a portion of the cells. 
Alternatively, the zygote can have a normal karyotype, but in a postzygotic mitosis, 
nondisjunction of chromosomes 21 takes place. 
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Structural aberrations of chromosome 21 as mosaics are always caused by postzygotic 
rearrangements. Carriers of mosaics with the aberrant cells occuring only in the gonads 
have an increased risk compared to the general population of the same age for the birth of a 
child with the aberration in all cells. 
The risk of mosaic carriers for a retardation or affected offspring can not be specified because 
of the different types of aberrant karyotypes and their unequal distribution in the organism. 
If the percentage of trisomic cells in all somatic tissues is small (0.5 – 5 %), the phenotype of 
the carrier can be normal.  
Carriers with mosaics have a better prognosis than carriers of non-mosaic trisomies, but 
there is always a risk of uneven distribution of pathologic cells in the various tissues. 
Therefore, only the analyses of cells type stemming from different germ layers can lead to a 
reliable prognosis concerning the development of the patient.  
3.8 Tetrasomy 21 
A specific type of hyperploidy 21 is the tetrasomy where the chromosome 21 is present for  
four times. In the literature, only single cases have been published (Gardner and Sutherland, 
2004). This abnormality can either consist of four free chromosomes 21 or of two normal 
chromosomes and in addition an isochromosome 21. The aberration is usually lethal in the 
conceptus in early pregnancy, but a mosaic constitution has been diagnosed in patients 
postnatally. 
4. Techniques for DS testing 
Many different cytogenetic as well as molecular-genetic techniques have been developed in 
the past to detect standard trisomy 21 and structural aberrations of chromosome 21. 
Whereas the “simple” detection of genomic imbalances can be performed with numerous 
molecular techniques (short tandem repeat typing, MLPA, molecular karyotyping), 
information on structural rearrangements is usually up till now achieved by classical 
microscopic methods, e.g. chromosome analysis and FISH. In future the development of high 
resolution next generation sequencing techniques will allow a nearly complete overview on all 
numerical and unbalanced structural rearrangements in one molecular assay. 
4.1 Chromosome analyses 
Chromosome investigation is the conventional cytogenetic method based on cells 
undergoing mitosis to obtain metaphase spreads. The chromosomes can be pre-treated and 
stained according to different protocols to induce specific banding patterns. By karyotyping, 
the specifically banded chromosomes can be arranged into seven groups (A to G) based on 
descending order of size and of the position of the centromere. According to the type of 
induced banding pattern, two subtypes can be defined: a) those resulting in bands 
distributed along the length of the whole chromosome, such as G-, Q- and R-bands, and b) 
those that stain specific chromosome structures (e.g. C-bands, nucleolus organizing regions, 
telomeric bands)(Shaffer et al., 2009). 
The advantage of classical cytogenetics is that both unbalanced as well as balanced 
chromosomal aberrations are detectable. However, the technique is limited by the microscopic 
solution. Therefore, imbalances <5 Mb are not analysable by routine cytogenetics. Another 
disadvantage is that the majority of cell types has  to be cultured in vitro either as a short-term 
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or long-term culture. The long culture times bear the risk of in-vitro chromosomal changes. The 
direct preparation of mitoses is only possible when analysing meristematic cells (bone marrow 
biopsies, trophoblast cells, germ cells and their precursors). This mehtod has the advantage 
that the chromosomal analysis reflects the situation in-vivo. 
Chromosome analyses are mainly done after lymphocyte culture from peripheral blood 
samples. The cells are easily obtained and stimulated to mitosis, and the time of cultivation 
is only 48-72h.  
The chromosomes are arranged in a formal karyotype, according to their size, centromere 
position, and banding pattern (Figure 2a) following the International System for Human 
Cytogenetic Nomenclature (ISCN; Shaffer et al. 2009). 
4.2 Fluorescence-in-situ-hybridization (FISH) 
FISH is a widely used method to analyse different target DNA sequences by supplying specific 
DNA - probes. It combines cytogenetic and molecular genetic techniques. The principle of 
FISH is the interaction of a labelled single-stranded DNA with a denatured metaphase or 
interphase.  
Since a much higher resolution than chromosome analysis, FISH is used to identify and 
characterise small structural chromosome aberrations in clinical cytogenetics, including 
microdeletions and microduplications. A precise and detailed breakpoint analysis is possible. 
However, a FISH investigation is only applicable if the aberration in question is suspected. 
At first this technique was restricted to metaphase analysis, meanwhile, it has gained 
importance in interphase diagnostics as well. In particular the latter procedure is extremely 
helpful to detect low-level mosaicism. Furthermore, it has enabled rapid prenatal testing for 
the frequent aneuploidies in the fetus, including trisomy 21 (for review: Caine et al., 2005). 
4.3 Microsatellite typing 
Short tandem repeat markers (STRs, microsatellites) are highly informative molecular 
markers which are easy to handle. STRs have been described as an abundant class of DNA - 
polymorphisms in the human genome, consisting of highly repetitive short DNA - 
sequences. They can be typed by using PCR and single-copy primers flanking the repeats, 
followed by denaturing on a high resolution gel or by capillary electrophoresis. In 1991, 
Petersen and co-workers were the first to describe the application of these markers in order 
to determine the parental origin of the extra chromosome in families with a trisomy 21 
patient. Meanwhile, numerous studies on the origin of unbalanced chromosomal 
aberrations have been published. 
It is the advantage of microsatellite analysis that it needs only minimal amounts of genomic 
DNA. Furthermore, it is a fast and simple method which is widely established. It is therefore 
not amazing that this technique is one of the most frequently used methods for rapid 
prenatal aneuploidy testing (Mann et al., 2004). It circumvents time-consuming cell 
cultivation and needs approximately 6-8 h from taking the sample to final report. In 
addition, the comparison of the allelic distribution of a fetus and his parents allows the 
exclusion of a maternal contamination in fetal DNA - samples. 
However, the technique does not allow the detection of balanced rearrangements. 
Furthermore, a reduced informativity of microsatellite markers might hamper the 
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4.4 Multiplex Ligation-dependent Probe Amplification (MLPA) 
Multiplex Ligation-dependent Probe Amplification (MLPA) is a simple, high  throughput   
method that allows detection of DNA copy number changes of up to 40 sequences in a 
single reaction. It is based on the semi-quantitative polymerase chain reaction principle and 
can be applied for detecting copy number changes and has been developed by MRC 
Holland (http://www.mlpa.com/). MLPA has rapidly gained acceptance in genetic 
diagnostic laboratories due to its simplicity compared to other methods, its relatively low 
costs, the capacity for high throughput, and its robustness. Typical for the MLPA is that not 
target sequences are amplified but MLPA probes that hybridise to the target sequence. In 
contrast to a standard multiplex PCR, a single pair of PCR primers is used for MLPA 
amplification. The resulting amplification products of an MLPA assay range between 130 
and 480 nucleotides in length and can be analysed by capillary electrophoresis. By 
comparing the peak pattern obtained to that of reference samples it can be delineated which 
sequences have aberrant copy numbers. The MLPA reaction can be divided into five major 
steps: 1) DNA denaturation and hybridisation of MLPA probes; 2) ligation reaction; 3) PCR 
reaction; 4) separation of amplification products by electrophoresis; and 5) data analysis. For 
trisomy 21 and further frequent aneuploidies (trisomies 13 and 18), an aneuploidy MLPA kit 
is commercially available. 
The advantage of MLPA is indeed the low amount of genomic DNA needed for genotyping 
and the fact that that parental samples are not necessary for comparison. However, the 
procedure is time-consuming and needs at least two days. 
4.5 Array analysis 
Molecular karyotyping is meanwhile a well established method to identify genomic 
imbalances. In particular the resolution is much better than that of conventional 
cytogenetics. While chromosome analysis detects imbalances (deletions and duplications) >5 
Mb, array typing has a resolution of <100 kb (figure 4). Microarray analysis allows the 
identification of any type of segmental imbalance by virtue of its design, but it does not 
allow the identification of balanced rearrangements or small mosaics. 
 
 
Fig. 4. Example of Micro-array based characterisation of a partial trisomy 21 in a patient 
affected by Silver-Russell syndrome (Eggermann et al., 2010). The patient did not exhibit 
any symptoms of DS, thus the trisomic region could be excluded to be involved in the 
specific phenotypic expression of DS. 
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As a large number of strategies and platforms are commercially available and cannot be 
covered here, we strongly emphasize checking the updated literature. Dependent on the 
array type, molecular karyotyping allows the detection of imbalances with a size of a few 
kb. And thus the detection rate for chromosomal aberrations in patients with mental 
retardation could be increased impressively (for review: Shaffer and Bejjani, 2010). 
However, the interpretation of microarray data is currently hampered by the large genomic 
instability mainly in non-coding regions, resulting in the analysis of a growing number of 
copy number variations (CNVs).  
Nevertheless, first guidelines for molecular karyotyping have recently been published 
(Vermeesch et al., 2010).  
4.6 Next generation sequencing 
Due to the development of genome-wide sequencing (next generation sequencing) the cheap 
and accurate characterisation of whole genomes in a short time has become possible. Indeed, 
the methods and applications are extremely manifold and can be merely covered in this short 
paragraph (for review: Metzker, 2010). Of course, it is too early to apply this complex 
technology for characterisation of whole chromosome aberrations like trisomy 21. However, 
target assays will be developed, and it has to be considered that next generation sequencing 
will allow to rapidly identify and reliably characterise genomic disturbances – balanced as well 
as unbalanced – and breakpoints in cases of structural rearrangements. 
5. Probability for the birth of a child with DS 
As the clinical symptoms of a child with the phenotype of DS cannot be considered as a 
reliable classification, the diagnosis must always be accompanied by a chromosome analysis. 
The occurrence of trisomy 21 in young mothers lead to screening investigations to ascertain 
whether exogeneous factors might play a role in the aetiology of trisomy 21 besides the well-
known genetic risk factors. 
5.1 Subjects for discussion on exogeneous risk factors 
Different substances known as mutagens, co-mutagens, and teratogens have been 
investigated in detail. 
The atomic bomb blasts in Japan at the end of the World War Two and the explosion of the 
atomic reactor in Chernobyl in 1986 are well-known examples of exposures and have been 
thoroughly explored. However, they did not lead to an increased birth of children with DS 
(Dean et al., 2000).  
Furthermore, neither contact with different organic substances or heavy metals nor an 
increased consumption of caffeine, alcohol, or nicotine could be shown to increase the 
number of births of children with trisomy 21 or other chromosome aberrations. 
5.2 Endogeneous risk factors 
This group encloses carriers of balanced and unbalanced chromosome 21 aberrations and 
includes the risk of advanced maternal age at pregnancy as well. 
5.2.1 Carriers of standard trisomy 21 
Adequate therapy has increased the life expectancy of carriers of trisomy 21 significantly 
within the last decades. Furthermore, a largerly normal life by a specific support of motor and 
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mental abilities has become possible for many DS individuals. This leads to pregnancies in DS 
women and makes adequate genetic counselling necessary. The theoretical risk for a woman 
with trisomy 21 to have a child with trisomy 21 is 50%, but it is reduced by the high amount of 
abortions in early pregnancy. An empirical risk of 30-40% can therefore be delineated. 
However, genetic counselling has also   to take into account the risks of a pregnancy in a DS 
woman suffering from malformations such as heart defects or kidney anomalies. Males with 
a trisomy 21 are usually sterile. 
5.2.2 Recurrence risk in carriers of mosaic trisomy 21 
In mosaic cases, the risk of a female or male in rare cases carrier to have a child with full trisomy 
21 cannot be estimated precisely, because only the amount of trisomic cells in the somatic 
tissues can be analysed but not the one in the gonads. The ratio of trisomic cells may even be 
100% in the ovaries and testes, leading to the same risk factor as in carriers with a full trisomy. 
A special situation is given if the carrier has a normal karyotype in all somatic cells 
investigated, and the trisomic cells are restricted to the gonads (parental germline 
mosaicism). In these cases the empiric recurrence risk is delineated as 1-2%, but in two cases 
of two or more pregnancies with trisomy 21 it is estimated to be much higher (empirical 
value of more than 10%) (Warburton et al., 2001). 
Mosaics are usually found in free trisomy 21 but mosaicism of translocation trisomy 21 has 
also been observed. 
5.2.3 Carriers of a balanced heterologous Robertsonian translocation 
Significant differences concerning risk factors have been observed   for female and male 
carriers of heterologous translocations. In female carriers, the empiric risk of having a child 
with an unbalanced translocation is about 10%, and in males it is only 1-2% (Ferguson-Smith, 
1983; Daniel et al., 1989). In both sexes, the translocations rob(14q21q) and rob(15q21q) harbour 
the additional risk of uniparental disomy 14 or 15 as a consequence of trisomic rescue (Kotzot 
and Utermann, 2005) which is  associated with specific clinical syndromes. 
5.2.4 Robertsonian translocation rob(21q21q) and isochromosome 21 
Balanced carriers of these two types of rearrangements have a risk of 100% that the offspring 
will inherit a translocation trisomy 21, regardless of the sex. 
5.2.5 Parents with a balanced reciprocal translocation 
In the rare group of parents carrying a balanced chromosome rearrangement affecting 
whole or partial 21q, the risk of having a child with a complete or partial trisomy 21 is 
relatively high, with about 20% in females and 10% in males. If the translocation 
chromosomes and their normal homologous show pairing difficulties in meiosis I, the 
additional risk of a 3:1 segregation has to be taken into account, leading to a recurrence risk 
of up to 30%. Offspring with an unbalanced translocation show monosomy of the 
heterologous chromosomal segment, in addition to the complete or partial trisomy 21. As a 
result, the phenotype will be complex and heterogeneous, depending on the origin of the 
second translocation chromosome. 
5.2.6 Parents with normal karyotype having a child with DS 
This is the main group of consultants. The maternal age at pregnancy is significantly 
elevated in the majority of cases, and therefore, an increased risk for elder women can be 
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delineated (risk of 1:1667 at 20 years and 1:32 at 45 years (Morris et al., 2002). There is a 
second slight increase of risk in very young mothers (1:1000 at 15 years). The probability for 
a child with DS is not correlated with paternal age.  
However, in a small cohort of families an age independent high risk for pregnancies with 
different trisomies has been observed (Munné et al., 2004; Baart et al., 2006). 
Molecular investigations made it probable that in these cases the increased aneuploidy rate 
is caused by an autosomal recessive mutation. To identify this group of carriers a thorough 
pedigree analysis is necessary, cytogenetic karyotyping is indicated for the consultants and 
their offspring – children and miscarriages. Failures from pregnancy induction by IVF (in-
vitro fertilisation) have to be included in the risk estimation. These couples are usually 
recommended to a special IVF program for   a further pregnancy, and preimplantation-
testing procedures might be considered (Stumm et al., 2006). 
5.2.7 Siblings and 3
rd
 degree relatives of a patient with DS 
Healthy relatives of a patient with a free trisomy 21 have no increased risk for the birth of a 
child with trisomy 21 when compared to the average population of the same age.  
Relatives of a proband with DS caused by an unbalanced structural rearrangement have an 
increased risk if they are balanced carriers of the translocation (see above). The risk factor 
depends on the type of rearrangement and on the sex of the carrier. 
5.2.8 Prenatal findings of symptoms characteristic for DS detectable by ultrasound 
At the end of the first trimester of pregnancy (10th to 12th week,) ultrasound investigations 
are routinely recommended. At that age, the majority of  fetuses with trisomy 21 show a 
number of characteristic features. These  include nuchal translucency, absence of nasal bone, 
heart defect and growth retardation. In the second trimester, the main symptoms detectable 
by ultrasonography are a flat occiput, a flat profile of the face, small nose, dysmorphic and 
deep seated ears, receding chin and short neck,  malformations of the internal organs, and 
growth retardation. 
These observations by ultrasound are an indication for prenatal chromosome analysis either 
by chorionic villi sampling (CVS) or by amniocentesis (AC). 
5.2.9 Comparison of invasive and non-invasive prenatal investigations 
Non-invasive methods 
The main technique in prenatal diagnostics is ultrasound. In Germany, it is usually applied 
three times during pregnancy. Ultrasound can meanwhile be regarded as a prerequisite for 
CVS, AC, or fetal blood sampling (FBS) since morphologic abnormalities are caused by a 
pathologic karyotype in 20-50% of the cases (personal observation).  
A second group of non-invasive parameters   are specific biochemical factors (AFP, ┚-HCG, 
estriol) analysed from maternal blood. They are combined with the risk delineated from the 
given maternal age. If the result differs from expectation and corresponds to an increased risk 
for DS, invasive methods to determine the karyotype are applied. 
A third possibility for non-invasive investigations in pregnancy is the analysis of fetal cells 
and fetal DNA in the maternal blood. By   special procedures, fetal DNA can be isolated and 
enriched from maternal blood, however, this method is still under development and is 
currently not applied in routine prenatal testing. 
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Invasive prenatal investigations 
Three different methods are usually applied: CVS in the first trimester, AC in the second, 
and AC, FBS, and placenta biopsy in the third. 
All three methods generally include an investigation risk of about 1%. Therefore, these 
methods should only be applied if the genetic risk is higher than the risk of investigation. 
Sometimes different methods have to be combined to receive a diagnosis. However, this 
increases the time of investigation and prolongs the psychological stress of the parents 
(Geskas et al., 2011).  
Usually, a reliable, final diagnosis can only be achieved by invasive investigations but the 
non-invasive methods enable the investigator to get information of an increased or 
decreased  extent of the pre-existing risk in the individual pregnancy. 
6. Comparison of type and contretype of DS 
As a full monosomy 21 is lethal in life-born children and also exceedingly rare in 
spontaneous abortions, the phenotype of carriers of this aberration is delineated from 
mosaic cases and partial deletions. The clinical findings revealed a number of symptoms, 
especially facial dysmorphic features that can be defined as opposite type  or “contretype”  
to patients with trisomy 21 (Table 1). 
 
Trisomy 21 Partial monosomy 21 
Muscular hypotonia Muscular hypertonia 
Overextension of joints Spasticity 
Hyperflexible fingers Camptodactyly 
Flat occiput Protuberant occiput 
Upslanting palpebral fissures Downslanting palpebral fissures 
Small round ears Large ears 
Aplastic nasal bridge Protuberant nasal bridge 
Table 1. Phenotypes of trisomy and (partial or mosaic) monosomy 21. (Schinzel, 2001) 
7. DS and uniparental disomy 
As trisomic rescue is the most frequent way of uniparental disomy formation, this type of 
cytogenetic aberration has to be discussed in context with trisomy 21. Uniparental disomy 
(UPD) is the inheritance of both homologous of a chromosome pair from only one parent. 
The concept of UPD was first postulated to cause specific phenotypes in the eighties (Engel, 
1980). This hypothesis was then confirmed by UPD of different chromosomes in association 
with typical syndromes. The best examples of this type of aberration are maternal UPD15 
(upd(15)mat) in Prader-Willi and paternal UPD15 (upd(15)pat) in Angelman syndrome.  
Different mechanisms may lead to UPD (Spence et al., 1988): each of them includes at least 
two errors either during meiosis or in postzygotic mitoses. During meiosis, a nondisjunction 
of two homologous chromosomes occurs, which leads to a trisomy in the zygote. In most 
cases, this zygote will not be viable, unless a correction or a “trisomic rescue” happens. 
Statistically, in one third of cases, the chromosome of the parent who did not contribute to 
the trisomy is lost, thus resulting in UPD.  
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A cytogenetic hint for a trisomy rescue is the confined placental mosaicism (CPM), which 
describes the presence of a partial chromosomal aberration (usually a trisomy mosaic) in the 
placenta but not in the fetus. This constitution can be diagnosed in approximately 1-2% of 
chorionic villous samples (Kalousek et al., 1989). CPM can have relevant clinical 
consequences since it may lead to placental insufficiency and then induces intrauterine 
growth retardation.  
Clinical features in context with UPD can be caused by: 
a. hidden chromosomal mosaicism originating by the UPD formation via trisomy rescue; 
b. by the imbalanced expression of imprinted genes in the respective chromosomal region 
resulting in a specific imprinting disorder; 
c. homozygosity for recessive mutations. Interestingly, this phenomenon led to the 
detection of the first case of UPD. Spence et al. (1988) reported a patient suffering from 
cystic fibrosis who was homozygous for the mutation F508del in the CFTR gene. Only 
his mother was a heterozygous carrier for F508del transmitting the mutant gene copy 
twice to her child. Therefore, UPD always involves the usually unpredictable risk for 
homozygosity of mutant genes in addition to imprinted gene effects.  
Due to the frequency of trisomy 21, UPD of this chromosome should be a well-known 
aberration. Indeed, maternal as well as paternal UPD21 (upd(21)mat, upd(21)pat) have been 
reported for several times (for review: Kotzot and Utermann, 2005), including healthy 
carriers. Based on the latter finding, it can be decided that the clinical course of upd(21)mat 
or upd(21)pat carriers is rather caused by a hidden chromosomal mosaicism which can be 
delineated from the UPD formation mechanism or by homozygosity of a recessive allele 
than by the UPD itself. Imprinted genes involved in the aetiology of imprinting disorders 
are not localised on chromosome 21. A different epigenetic effect was shown by recent 
investigations. 
It could be demonstrated that trisomy 21 affects the methylation pattern of different 
heterologous chromosomes by decreasing their extent of methylation (Weinhaeusel et al., 
2011) and thus leas to clinical abnormalitiesof the carrier. 
8. The simultaneous occurrence of trisomy 21 and other chromosomal 
aberrations 
This group of combined aberrations comprises numerical and structural abnormalities which 
present as pathologic karyotype in all cells of an organism or as different types of mosaicism. 
Investigations usually rely on conventional chromosome analyses of spontaneous abortions 
as in this group the frequency among conceptus with pathological karyotype is about 25% 
compared to life-born children with 0.2% (own investigations and findings from the 
literature). 
8.1 Double aneuploidies 
Trisomy 21 can be combined with aneuploidies of different heterologous chromosomes 
(Micale et al., 2010). The maternal age of a pregnancy with a conceptus showing a double 
aneuploidy is on average higher than that with a single trisomy. The life expectance of the 
carrier is lower in prenatal and postnatal period than in single trisomies. Double trisomies of 
autosomes show a higher lethality than combinations of autosomes and gonosomes. 
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8.1.1 Combinations with gonosome aberrations 
Gonosomal aneuploidies in patients with an additional trisomy 21 were diagnosed in the 
four possible combinations with monosomy X, XXY, XYY and XXX. The most frequent 
gonosome aberration in this context is XXY. Monosomy X often presents as mosaic. 
The phenotype of the patients usually corresponds to that of trisomy 21. The reason might 
be the inactivation of more than one X chromsome and the low number of genes on the Y 
chromosome. The combinations of these double aneuploidies are more frequent than the 
total amount of the two single trisomies, or the trisomy combined with that of monosomy X. 
8.1.2 Combinations with heterologous autosome aberrations 
In life-born children, only three combinations of trisomy 21 with additional heterologous 
chromosomes have been observed: +8, +13, +18, and trisomy 8 is always occurring as 
mosaic. The double trisomy 21 and 18 seems to be the most frequent combination with an 
average of 1:1000 among trisomy 21 carriers. The frequency of this combination is much 
higher in spontaneous abortions with about 2.5 in 100 trisomies. This is explained by the 
high and early lethality of conceptus with a double autosomal trisomy. 
Clinical investigations reveal a heterogenous picture: The carrier can show the phenotype of 
one of the 2 trisomies or a combination of both. The majority of double trisomies presents as 
a mosaic with one or two trisomic cell lines. 
8.2 Trisomy 21 in combination with structural aberrations 
The most frequent aberration is a trisomy 21 in combination with a balanced Robertsonian 
translocation rob(13q14q). It has been hypothesized that a familial translocation  rob(13q14q) 
induces frequently errors of pairing of heterologous chromosomes in the prophase of 
meiosis I leading to an aneuploid gamete (interchromosomal effect). Recent investigations 
could not prove this hypothesis. It is nowadays assumed that the reduced fertility of the 
translocation carriers is the reason for pregnancies at increased maternal age, which leads to 
an elevated risk for pregnancies with trisomy 21. 
Further single cases of trisomy 21 combined with structural aberrations comprise 
unbalanced and balanced reciprocal translocations, deletions, and sub-microscopic 
aberrations. 
9. Differential diagnoses 
Carriers of trisomy 21 are characterised by a number of clinical symptoms caused by 
disturbances during early embryonic development. This abnormal course of differentiation 
can also occur in other syndromes based on an aberrant embryogenesis.  
These syndromes can be caused by other chromosome abnormalities, by monogenic 
mutations, and by exogeneous factors or teratogenic agents. 
Chromosome syndromes with a phenotype that, especially in early childhood, resembles 
that of children with trisomy 21 are the two poly-X syndromes, penta-X syndrome in the 
female, and XXXXY in the male.  
A monogenic disease with a phenotype similar to that of trisomy 21 is hypothyroidism. 
The best-known differential diagnosis to trisomy 21 though, is fetal alcohol syndrome. 
The similarity between them is so high and the facial dysmorphic features are so 
characteristic for both that even in the general population the typical phenotype is well-
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known but often misinterpreted. Therefore, it may happen that a child with DS is wrongly 
mistaken as one with fetal alcohol syndrome and which can lead to discrimination of the 
family. 
The possibility that the phenotype of DS may be caused by other diseases than trisomy 21 
makes it necessary for all patients with the clinical diagnosis of DS to be investigated 
cytogenetically because otherwise prognosis, therapy, and estimation of recurrence risk 
might not be correct. 
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